NCT04173195 is a NA clinical trial of Comfort Talk in Chemotherapy Effect, sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal.

What drugs are being tested in NCT04173195?

Interventions in NCT04173195: Comfort Talk.

What condition does NCT04173195 study?

NCT04173195 studies Chemotherapy Effect.

Is NCT04173195 still recruiting?

NCT04173195 is currently completed. Last updated 29 March 2022.

Last reviewed 2022-03-29 · How we verify

NCT04173195

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comfort Talk (CT) During Outpatient Chemotherapy

Completed NA Last updated 29 March 2022

What this trial tests

NA trial testing Comfort Talk in Chemotherapy Effect in 49 participants. Completed in 31 March 2020.

Timeline

23 September 2019

Primary endpoint
22 December 2019

31 March 2020

Quick facts

Lead sponsor	Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	49
Start date	23 September 2019
Primary completion	22 December 2019
Estimated completion	31 March 2020
Sites	1 location across Canada

Drugs / interventions tested

Comfort Talk

Conditions studied

Chemotherapy Effect — all drugs for Chemotherapy Effect →

Sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal — full company profile →

Who can join

18 and older, any sex, with Chemotherapy Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Emotional support and physical comfort are two important components of the patient experience at the oncology outpatient clinic. However, current practices do not seem optimal for meeting the psychosocial needs expressed by patients during chemotherapy treatments. Comfort talk (CT) is a simple, inexpensive intervention that could maximize the feeling of safety and comfort during chemotherapy. Identifying interventions that are interdisciplinary and that can enhance the outpatient patient experience will facilitate access to quality oncology care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility and acceptability of hypnosis-derived communication administered by trained nurses to improve patient well-being during outpatient chemotherapy: a pilot-controlled trial.
Arbour C, Tremblay M, Ogez D, Martineau-Lessard C, et al · · 2022 · cited 6× · PMID 34374847 · DOI 10.1007/s00520-021-06481-6

Verify or expand the search:

Other recruiting trials for Chemotherapy Effect

Currently open trials in the same condition.

NCT06525402 — Effect of Sodium Bicarbonate, Saline and Black Mulberry Syrup on Degree of Oral Mucositis in Children Receiving Chemothe · NA · recruiting
NCT06510010 — Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer · Phase 2 · recruiting
NCT06944587 — A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer · recruiting
NCT05864274 — Improve Cancer-related Cognitive Impairment · NA · recruiting
NCT06863623 — The Effect of Immersive Virtual Reality and Relaxing Videos on Lung Cancer Patients · NA · recruiting

Other Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal trials

Trials by the same sponsor.

NCT07508514 — Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA · not yet recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT06971315 — Impact of Vitamin C on Pain Detection and Tolerance Threshold · NA · completed
NCT06120608 — Evidence for Potassium Restriction in Hemodialysis · NA · active not recruiting
NCT06920537 — Postpartum CO Rehabilitation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04173195 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Last refreshed: 29 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing